Viveve Medical GAAP EPS of -$0.59 beats by $0.07, revenue of $17M beats by $15.29M

Nov. 10, 2022 4:44 PM ETViveve Medical, Inc. (VIVE)By: Urvi Shah, SA News Editor
  • Viveve Medical press release (NASDAQ:VIVE): Q3 GAAP EPS of -$0.59 beats by $0.07.
  • Revenue of $17M (+962.5% Y/Y) beats by $15.29M.
  • Gross profit for the third quarter of 2022 was $0.5 million, or 32% of revenue, compared to gross profit of $0.1 million, or 7% of revenue, for the same period in 2021.

  • Cash and cash equivalents were $5.9 million as of September 30, 2022, compared to $19.2 million as of December 31, 2021.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.